trial · primary record
Volrustomig
Unresectable Pleural Mesothelioma
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 863 |
| Primary completion | 2028-11-16 |
| Primary endpoint | Overall Survival (OS) in experimental arm relative to comparator arm |
| Registry ID | NCT06097728 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:27.212Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06097728
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.